AmgenAMGNEarnings & Financial Report
Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| The Vanguard Group | 9.16% | 49.0M | — | 2024-02-13 |
| BlackRock, Inc. | 8.90% | 47.8M | — | 2024-01-25 |
| STATE STREET CORPORATION | 5.52% | 31.2M | — | 2024-01-30 |
| SAGA INVESTMENTS COÖPERATIEF U.A. | 0.00% | 62.5M | — | 2024-08-23 |
Insider Transactions
Net 90d: −$20.77M · buys $0 / sells $20.77MRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-04 | Bradway Robert A | Chairman, CEO and President | Option exercise | 119.8K | $156.35 | $18.73M |
| 2026-03-03 | REESE DAVID M | EVP & Chief Technology Officer | Grant | 12.1K | $0.00 | $0 |
| 2026-03-03 | Derek Miller | SVP, Human Resources | Grant | 3.5K | $0.00 | $0 |
| 2026-03-03 | Rachna Khosla | SVP, Business Development | Grant | 1.9K | $0.00 | $0 |
| 2026-03-03 | Griffith Peter H. | EVP & CFO | Grant | 12.1K | $0.00 | $0 |
| 2026-03-03 | Graham Jonathan P | EVP & Gen. Counsel & Sec. | Grant | 10.7K | $0.00 | $0 |
| 2026-03-03 | Grygiel Nancy A. | SVP & CCO | Grant | 2.0K | $0.00 | $0 |
| 2026-03-03 | Bradway Robert A | Chairman, CEO and President | Grant | 42.7K | $0.00 | $0 |
| 2026-03-03 | Esteban Santos | EVP, Operations | Grant | 11.3K | $0.00 | $0 |
| 2026-03-03 | Murdo Gordon | EVP, Global Commercial Ops | Grant | 13.4K | $0.00 | $0 |
1–10 of 15
Page 1 / 2